Skip to content Skip to sidebar Skip to footer

Widget HTML #1

Biogen, citing insurance challenges, shutters one of its Aduhelm studies

Biogen, citing insurance challenges, shutters one of its Aduhelm studies

Following a ruling by the US federal insurance program, Medicare, a company claims it was forced t… Read more Biogen, citing insurance challenges, shutters one of its Aduhelm studies